查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1980323

益生菌市場規模、佔有率、成長及全球產業分析：按類型和應用分類，區域洞察及2026-2034年預測

Probiotics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 請詢問到貨日

價格

益生菌市場成長要素

全球益生菌市場預計到2025年將達到731.3億美元，從2026年的774億美元成長到2034年的1,345億美元，2026年至2034年的複合年成長率為7.15%。亞太地區在2025年將以48.35%的市場佔有率引領市場，這得益於可支配收入的成長、中產階級的壯大以及益生菌強化食品和飲料消費量的增加。

益生菌是添加到食品、飲料、營養補充劑、動物飼料和化妝品中的活性微生物，旨在促進腸道菌叢平衡和整體健康。消費者對消化健康、免疫力和預防醫學的日益關注，正顯著加速全球對益生菌的需求。

市場動態

市場促進因素

向功能性食品和飲料轉型

消費者正從傳統食品轉向含有益生菌的機能性食品。不含乳製品、植物來源以及具有特定功效的益生菌產品正獲得廣泛認可。製造商們推出了一系列專注於特定菌株的產品，旨在解決消化器官系統問題、增強免疫力並促進整體健康。微生物組解決方案的持續創新正進一步推動市場成長。

市場限制因素

製造成本高，定價高

益生菌菌株的生產需要專門的基礎設施、先進的發酵技術和臨床檢驗。因此，生產成本高昂，含益生菌產品的價格也較高。開發中國家對價格的敏感度可能會限制這些產品的流通，尤其是在中低收入消費者群體中。

市場機遇

電子商務平台擴張

線上零售通路的快速成長正在提升全球消費者獲取益生菌產品的便利性。直接面對消費者的銷售模式、個人化訂閱模式以及精準的數位行銷宣傳活動，正助力製造商拓展基本客群。網路普及率的不斷提高和消費者對便利性的需求，也為益生菌產品創造了強勁的成長機會。

市場趨勢

個人化營養與先進配方

根據個人微生物組特徵量身訂製的個人化益生菌解決方案正成為產業發展的重要趨勢。各公司正利用先進的生物技術和微生物組研究，開發客製化的營養補充品和機能飲料。低糖、成分簡化的潔淨標示產品也越來越受到注重健康的消費者的青睞。

細分分析

按原料

在市場細分中，它們被分為細菌、酵母和其他。

  • 以乳酸桿菌和雙叉桿菌等經臨床驗證有效的菌株為主導的細菌類產品預計到2026年將引領市場，佔據86.77%的市場佔有率。這些菌株因其對消化器官系統和免疫系統健康的益處而被廣泛用於優格和膳食補充劑中。
  • 酵母市場預計將以 6.06% 的複合年成長率成長，這得益於其穩定性和互補的健康益處。

依產品類型

市場區隔分為食品飲料、保健品、動物飼料和化妝品。

  • 預計到 2026 年，食品飲料產業將佔據市場主導地位，市佔率達到 61.76%，這主要得益於對乳製品益生菌飲料、功能性穀物和非乳製品飲料的需求。
  • 受針對特定健康挑戰和客製化營養解決方案的需求不斷成長的推動，營養補充品市場預計將以 6.30% 的複合年成長率成長。
  • 隨著其在飼料中的應用日益廣泛，其應用範圍也變得更加多樣化。

透過使用

  • 到 2026 年，在預防醫學意識不斷增強的推動下，人類市場預計將佔據最大的市場佔有率，達到 94.81%。
  • 預計動物領域將以 5.59% 的複合年成長率成長，這主要得益於畜牧業、水產養殖業和寵物營養領域使用量的增加。

按形式

  • 由於液態益生菌具有高生物利用度和快速吸收的特點，預計到 2026 年，液態益生菌將佔據 53.54% 的市場佔有率。
  • 由於保存期限長，且適用於補充劑和嬰兒配方奶粉，預計粉狀配方奶粉的年複合成長率將達到 6.90%。

透過分銷管道

  • 由於品牌知名度高，且商品易於購買，超級市場和大賣場佔據了最大的市場佔有率。
  • 線上零售/電子商務是成長最快的管道，預計年複合成長率將達到 7.47%，這主要得益於便利性和不斷擴大的數位基礎設施。

區域展望

亞太地區

預計到2025年，亞太地區市場規模將達到353.6億美元，並繼續維持其主導地位。中國和日本是主要貢獻者，預計到2026年，兩國市場規模將分別達到140.8億美元和83億美元。由於中產階級需求的成長，印度市場也正在迅速崛起。

歐洲

預計到 2025 年，歐洲仍將是第二大市場，市場規模將達到 132.1 億美元。在對發酵乳製品和腸道健康補充劑的強勁需求推動下，該地區預計將以 6.23% 的複合年成長率成長。

北美洲

預計到 2025 年，北美市場規模將達到 99.2 億美元，而美國市場預計到 2026 年將達到 105 億美元。人們對腸道健康和預防保健的高度重視正在推動市場需求。

南美洲、中東和非洲

預計到2025年，南美洲市場規模將達到68億美元，主要得益於機能性食品日益普及。中東和非洲地區預計將保持穩定成長，這得益於人們對營養和預防醫學日益成長的興趣。

目錄

第1章：引言

第2章執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 母市場及相關市場概覽
  • 供應鏈分析
  • 監管分析
  • 產業SWOT分析
  • 近期產業趨勢：政策、併購、新產品發布

第5章：全球益生菌市場分析、洞察與預測（2026-2034年）

  • 主要發現與總結
  • 市場規模估算與預測
    • 依產品類型
      • 食品/飲料
      • 補充
      • 動物飼料
      • 化妝品
    • 來源
      • 細菌
      • 酵母菌
      • 其他
    • 按形式
      • 粉末
    • 按最終用途
      • 人類
    • 透過分銷管道
      • 超級市場和大賣場
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 南美洲
      • 中東和非洲

第6章：北美益生菌市場分析、洞察與預測（2026-2034年）

  • 國家
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲益生菌市場分析、洞察與預測（2026-2034年）

  • 國家
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家

第8章：亞太益生菌市場分析、洞察與預測（2026-2034年）

  • 國家
    • 中國
    • 印度
    • 日本
    • 東南亞
    • 澳洲
    • 其他亞太國家

第9章：南美益生菌市場分析、洞察與預測（2026-2034年）

  • 國家
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章：中東和非洲益生菌市場分析、洞察與預測（2026-2034年）

  • 國家
    • UAE
    • 南非
    • 其他中東和非洲國家

第11章：競爭矩陣

  • 主要企業採取的商務策略
  • 全球益生菌市場收入佔有率及排名分析：按主要生產商分類，2025 年

第12章：公司簡介

  • Yakult Honsha Co., Ltd.

第13章 其他企業資料

  • Danone SA
  • Nestle SA
  • Chr. Hansen Holding A/S
  • DuPont Nutritona dn Biosciences
  • BioGaia AB
  • Probi AB
  • ADM
  • Kerry Group Plc
  • Meiji Holdings Co., Ltd.

第14章 戰略建議

第15章附錄

Product Code: FBI100083

Growth Factors of probiotics Market

The global probiotics market was valued at USD 73.13 billion in 2025 and is projected to grow from USD 77.40 billion in 2026 to USD 134.50 billion by 2034, exhibiting a CAGR of 7.15% during 2026-2034. Asia Pacific dominated the market with a 48.35% share in 2025, supported by rising disposable incomes, expanding middle-class populations, and growing consumption of probiotic-enriched foods and beverages.

Probiotics are live microorganisms incorporated into food, beverages, dietary supplements, animal feed, and cosmetics to promote gut microbiota balance and overall health. Increasing consumer awareness regarding digestive health, immunity, and preventive healthcare is significantly accelerating global demand.

Market Dynamics

Market Drivers

Shift Toward Functional Food and Beverages

Consumers are increasingly transitioning from traditional food products to functional foods enriched with probiotics. Dairy-free, plant-based, and targeted probiotic formulations are gaining strong traction. Manufacturers are introducing strain-specific products designed to address digestive disorders, immunity enhancement, and overall wellness. Continuous innovation in microbiome-based solutions is further strengthening market growth.

Market Restraints

High Production Costs and Premium Pricing

The manufacturing of probiotic strains requires specialized infrastructure, advanced fermentation technologies, and clinical validation. This results in higher production costs, leading to premium pricing of probiotic-enriched products. Price sensitivity in developing economies may restrict adoption, particularly among middle- and lower-income consumers.

Market Opportunities

Expansion of E-Commerce Platforms

Rapid growth in online retail channels is enhancing accessibility of probiotic products globally. Direct-to-consumer sales, personalized subscription models, and targeted digital marketing campaigns are enabling manufacturers to expand their customer base. Rising internet penetration and convenience-driven shopping behavior are creating strong growth opportunities.

Market Trends

Personalized Nutrition and Advanced Formulations

Personalized probiotic solutions tailored to individual microbiome profiles are emerging as a key industry trend. Companies are leveraging advanced biotechnology and microbiome research to develop customized dietary supplements and functional beverages. Clean-label products with reduced sugar and simplified ingredients are also gaining popularity among health-conscious consumers.

Segmentation Analysis

By Source

The market is segmented into bacteria, yeast, and others.

  • The bacteria segment is expected to dominate with 86.77% share in 2026, driven by clinically validated strains such as Lactobacillus and Bifidobacterium. These strains are widely used in yogurt and supplements for digestive and immune health benefits.
  • The yeast segment is projected to grow at a CAGR of 6.06%, supported by its stability and complementary health benefits.

By Product Type

The market is segmented into food & beverages, supplements, animal feed, and cosmetics.

  • Food & beverages are projected to dominate with a 61.76% share in 2026, driven by demand for dairy-based probiotic drinks, functional cereals, and non-dairy beverages.
  • Supplements are expected to grow at a CAGR of 6.30%, supported by increasing demand for targeted health solutions and customized nutrition.
  • Expanding use in animal feed is further diversifying applications.

By End Use

  • The human segment holds the largest share at 94.81% in 2026, driven by rising preventive healthcare awareness.
  • The animal segment is projected to grow at a CAGR of 5.59%, supported by increasing use in livestock, aquaculture, and pet nutrition.

By Form

  • Liquid probiotics account for 53.54% share in 2026, owing to higher bioavailability and faster absorption.
  • Powder form is projected to grow at a 6.90% CAGR, driven by longer shelf life and suitability for supplements and infant formula.

By Distribution Channel

  • Supermarkets & hypermarkets hold the largest share due to brand visibility and wide product availability.
  • Online retail/e-commerce is the fastest-growing channel, projected to grow at a CAGR of 7.47%, driven by convenience and expanding digital infrastructure.

Regional Outlook

Asia Pacific

Asia Pacific reached USD 35.36 billion in 2025, maintaining its dominant position. China and Japan are key contributors, with projected 2026 valuations of USD 14.08 billion and USD 8.30 billion, respectively. India is also emerging rapidly due to expanding middle-class demand.

Europe

Europe is valued at USD 13.21 billion in 2025 and remains the second-largest region. The region is projected to grow at a CAGR of 6.23%, supported by strong demand for fermented dairy products and gut health supplements.

North America

North America is estimated at USD 9.92 billion in 2025, with the U.S. market projected to reach USD 10.50 billion in 2026. High awareness of gut health and preventive wellness supports demand.

South America & Middle East & Africa

South America recorded USD 6.80 billion in 2025, driven by rising adoption of functional foods. The Middle East & Africa region is expected to grow steadily, supported by increasing focus on nutrition and preventive healthcare.

Competitive Landscape

The market features established multinational players and biotechnology firms. Key companies include Yakult Honsha Co., Ltd., Danone S.A., Nestle S.A., Chr. Hansen Holding A/S, DuPont Nutrition & Biosciences, BioGaia AB, Probi AB, ADM, Kerry Group Plc, and Meiji Holdings Co., Ltd. Companies are focusing on product portfolio expansion, strain innovation, and research & development to maintain competitive advantage.

Conclusion

The global probiotics market is set to expand from USD 73.13 billion in 2025 to USD 134.50 billion by 2034, driven by rising consumer awareness of digestive health, preventive healthcare trends, and functional food demand. While high production costs pose challenges, expanding e-commerce channels, personalized nutrition solutions, and ongoing strain innovation will continue to propel market growth. With Asia Pacific leading and developed markets steadily expanding, the probiotics industry is positioned for sustainable and long-term expansion through 2034.

Segmentation By Source, Product Type, Form, End Use, Distribution Channel, and Region

By Product Type Food and Beverages

  • Dairy-based products
  • Non-dairy based beverages
  • Cereals & snacks
  • Baked food
  • Frozen & confectionery
  • Ready-to-eat packaged meals

Supplements

  • Nutritional supplements
  • Specialty supplements
  • Infant formula

Animal Feed

Cosmetics

By Source Bacteria

  • Lactobacillus
  • Bifidobacterium
  • Others

Yeast

Others

By Form * Powder

  • Liquid
  • Encapsulated
  • Others

By End Use * Human

  • Animal

By Distribution Channel * Supermarkets & Hypermarkets

  • Pharmacies & Drug Stores
  • Health & Specialty Stores
  • Online Retail / E-commerce
  • Others

By Geography North America (By Source, Product Type, Form, End Use, Distribution Channel , and Country)

  • U.S. (By Form)
  • Canada (By Form)
  • Mexico (By Form)

Europe (By Source, Product Type, Form, End Use, Distribution Channel, and Country)

  • Germany (By Form)
  • U.K. (By Form)
  • Spain (By Form)
  • France (By Form)
  • Italy (By Form)
  • Rest of Europe (By Form)

Asia Pacific (By Source, Product Type, Form, End Use, Distribution Channel, and Country)

  • China (By Form)
  • India (By Form)
  • Australia (By Form)
  • Japan (By Form)
  • Southeast Asia (By Form)
  • Rest of the Asia Pacific (By Form)

South America (By Source, Product Type, Form, End Use, Distribution Channel , and Country)

  • Brazil (By Form)
  • Argentina (By Form)
  • Rest of South America (By Form)

Middle East and Africa (By Source, Product Type, Form, End Use, Distribution Channel and Country)

  • UAE (By Form)
  • South Africa (By Form)

Rest of the Middle East & Africa (By Form)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Market Overview of Related/Parent Market
  • 4.2. Supply Chain Analysis
  • 4.3. Regulatory Analysis
  • 4.4. Industry SWOT Analysis
  • 4.5. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches

5. Global Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Size Estimates and Forecast
    • 5.2.1. By Product Type (Value)
      • 5.2.1.1. Food and Beverages
        • 5.2.1.1.1. Dairy-based products
        • 5.2.1.1.2. Non-dairy based beverages
        • 5.2.1.1.3. Cereals & snacks
        • 5.2.1.1.4. Baked food
        • 5.2.1.1.5. Frozen & confectionery
        • 5.2.1.1.6. Ready-to-eat packaged meals
      • 5.2.1.2. Supplements
        • 5.2.1.2.1. Nutritional supplements
        • 5.2.1.2.2. Specialty supplements
        • 5.2.1.2.3. Infant formula
      • 5.2.1.3. Animal Feed
      • 5.2.1.4. Cosmetics
    • 5.2.2. By Source (Value)
      • 5.2.2.1. Bacteria
        • 5.2.2.1.1. Lactobacillus
        • 5.2.2.1.2. Bifidobacterium
        • 5.2.2.1.3. Others
      • 5.2.2.2. Yeast
      • 5.2.2.3. Others
    • 5.2.3. By Form (Value)
      • 5.2.3.1. Powder
        • 5.2.3.1.1. Liquid
        • 5.2.3.1.2. Encapsulated
        • 5.2.3.1.3. Others
    • 5.2.4. By End Use (Value)
      • 5.2.4.1. Human
        • 5.2.4.1.1. Animal
    • 5.2.5. By Distribution Channel (Value)
      • 5.2.5.1. Supermarkets & Hypermarkets
        • 5.2.5.1.1. Pharmacies & Drug Stores
        • 5.2.5.1.2. Health & Specialty Stores
        • 5.2.5.1.3. Online Retail / E-commerce
        • 5.2.5.1.4. Others
    • 5.2.6. By Region (Value)
      • 5.2.6.1. North America
      • 5.2.6.2. Europe
      • 5.2.6.3. Asia Pacific
      • 5.2.6.4. South America
      • 5.2.6.5. Middle East & Africa

6. North America Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Size Estimates and Forecast
    • 6.2.1. By Product Type (Value)
      • 6.2.1.1. Food and Beverages
        • 6.2.1.1.1. Dairy-based products
        • 6.2.1.1.2. Non-dairy based beverages
        • 6.2.1.1.3. Cereals & snacks
        • 6.2.1.1.4. Baked food
        • 6.2.1.1.5. Frozen & confectionery
        • 6.2.1.1.6. Ready-to-eat packaged meals
      • 6.2.1.2. Supplements
        • 6.2.1.2.1. Nutritional supplements
        • 6.2.1.2.2. Specialty supplements
        • 6.2.1.2.3. Infant formula
      • 6.2.1.3. Animal Feed
      • 6.2.1.4. Cosmetics
    • 6.2.2. By Source (Value)
      • 6.2.2.1. Bacteria
        • 6.2.2.1.1. Lactobacillus
        • 6.2.2.1.2. Bifidobacterium
        • 6.2.2.1.3. Others
      • 6.2.2.2. Yeast
      • 6.2.2.3. Others
    • 6.2.3. By Form (Value)
      • 6.2.3.1. Powder
        • 6.2.3.1.1. Liquid
        • 6.2.3.1.2. Encapsulated
        • 6.2.3.1.3. Others
    • 6.2.4. By End Use (Value)
      • 6.2.4.1. Human
        • 6.2.4.1.1. Animal
    • 6.2.5. By Distribution Channel (Value)
      • 6.2.5.1. Supermarkets & Hypermarkets
        • 6.2.5.1.1. Pharmacies & Drug Stores
        • 6.2.5.1.2. Health & Specialty Stores
        • 6.2.5.1.3. Online Retail / E-commerce
        • 6.2.5.1.4. Others
    • 6.2.6. By Country
      • 6.2.6.1. U.S.
        • 6.2.6.1.1. By Form (Value)
          • 6.2.6.1.1.1. Powder
          • 6.2.6.1.1.2. Liquid
          • 6.2.6.1.1.3. Encapsulated
          • 6.2.6.1.1.4. Others
      • 6.2.6.2. Canada
        • 6.2.6.2.1. By Form (Value)
          • 6.2.6.2.1.1. Powder
          • 6.2.6.2.1.2. Liquid
          • 6.2.6.2.1.3. Encapsulated
          • 6.2.6.2.1.4. Others
      • 6.2.6.3. Mexico
        • 6.2.6.3.1. By Form (Value)
          • 6.2.6.3.1.1. Powder
          • 6.2.6.3.1.2. Liquid
          • 6.2.6.3.1.3. Encapsulated
          • 6.2.6.3.1.4. Others

7. Europe Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Size Estimates and Forecast
    • 7.2.1. By Product Type (Value)
      • 7.2.1.1. Food and Beverages
        • 7.2.1.1.1. Dairy-based products
        • 7.2.1.1.2. Non-dairy based beverages
        • 7.2.1.1.3. Cereals & snacks
        • 7.2.1.1.4. Baked food
        • 7.2.1.1.5. Frozen & confectionery
        • 7.2.1.1.6. Ready-to-eat packaged meals
      • 7.2.1.2. Supplements
        • 7.2.1.2.1. Nutritional supplements
        • 7.2.1.2.2. Specialty supplements
        • 7.2.1.2.3. Infant formula
      • 7.2.1.3. Animal Feed
      • 7.2.1.4. Cosmetics
    • 7.2.2. By Source (Value)
      • 7.2.2.1. Bacteria
        • 7.2.2.1.1. Lactobacillus
        • 7.2.2.1.2. Bifidobacterium
        • 7.2.2.1.3. Others
      • 7.2.2.2. Yeast
      • 7.2.2.3. Others
    • 7.2.3. By Form (Value)
      • 7.2.3.1. Powder
        • 7.2.3.1.1. Liquid
        • 7.2.3.1.2. Encapsulated
        • 7.2.3.1.3. Others
    • 7.2.4. By End Use (Value)
      • 7.2.4.1. Human
        • 7.2.4.1.1. Animal
    • 7.2.5. By Distribution Channel (Value)
      • 7.2.5.1. Supermarkets & Hypermarkets
        • 7.2.5.1.1. Pharmacies & Drug Stores
        • 7.2.5.1.2. Health & Specialty Stores
        • 7.2.5.1.3. Online Retail / E-commerce
        • 7.2.5.1.4. Others
    • 7.2.6. By Country
      • 7.2.6.1. Germany
        • 7.2.6.1.1. By Form (Value)
          • 7.2.6.1.1.1. Powder
          • 7.2.6.1.1.2. Liquid
          • 7.2.6.1.1.3. Encapsulated
          • 7.2.6.1.1.4. Others
      • 7.2.6.2. U.K.
        • 7.2.6.2.1. By Form (Value)
          • 7.2.6.2.1.1. Powder
          • 7.2.6.2.1.2. Liquid
          • 7.2.6.2.1.3. Encapsulated
          • 7.2.6.2.1.4. Others
      • 7.2.6.3. France
        • 7.2.6.3.1. By Form (Value)
          • 7.2.6.3.1.1. Powder
          • 7.2.6.3.1.2. Liquid
          • 7.2.6.3.1.3. Encapsulated
          • 7.2.6.3.1.4. Others
      • 7.2.6.4. Italy
        • 7.2.6.4.1. By Form (Value)
          • 7.2.6.4.1.1. Powder
          • 7.2.6.4.1.2. Liquid
          • 7.2.6.4.1.3. Encapsulated
          • 7.2.6.4.1.4. Others
      • 7.2.6.5. Spain
        • 7.2.6.5.1. By Form (Value)
          • 7.2.6.5.1.1. Powder
          • 7.2.6.5.1.2. Liquid
          • 7.2.6.5.1.3. Encapsulated
          • 7.2.6.5.1.4. Others
      • 7.2.6.6. Rest of Europe
        • 7.2.6.6.1. By Form (Value)
          • 7.2.6.6.1.1. Powder
          • 7.2.6.6.1.2. Liquid
          • 7.2.6.6.1.3. Encapsulated
          • 7.2.6.6.1.4. Others

8. Asia Pacific Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 8.1. Key Findings / Summary
    • 8.1.1. By Product Type (Value)
      • 8.1.1.1. Food and Beverages
        • 8.1.1.1.1. Dairy-based products
        • 8.1.1.1.2. Non-dairy based beverages
        • 8.1.1.1.3. Cereals & snacks
        • 8.1.1.1.4. Baked food
        • 8.1.1.1.5. Frozen & confectionery
        • 8.1.1.1.6. Ready-to-eat packaged meals
      • 8.1.1.2. Supplements
        • 8.1.1.2.1. Nutritional supplements
        • 8.1.1.2.2. Specialty supplements
        • 8.1.1.2.3. Infant formula
      • 8.1.1.3. Animal Feed
      • 8.1.1.4. Cosmetics
    • 8.1.2. By Source (Value)
      • 8.1.2.1. Bacteria
        • 8.1.2.1.1. Lactobacillus
        • 8.1.2.1.2. Bifidobacterium
        • 8.1.2.1.3. Others
      • 8.1.2.2. Yeast
      • 8.1.2.3. Others
    • 8.1.3. By Form (Value)
      • 8.1.3.1. Powder
        • 8.1.3.1.1. Liquid
        • 8.1.3.1.2. Encapsulated
        • 8.1.3.1.3. Others
    • 8.1.4. By End Use (Value)
      • 8.1.4.1. Human
        • 8.1.4.1.1. Animal
    • 8.1.5. By Distribution Channel (Value)
      • 8.1.5.1. Supermarkets & Hypermarkets
        • 8.1.5.1.1. Pharmacies & Drug Stores
        • 8.1.5.1.2. Health & Specialty Stores
        • 8.1.5.1.3. Online Retail / E-commerce
        • 8.1.5.1.4. Others
    • 8.1.6. By Country
      • 8.1.6.1. China
        • 8.1.6.1.1. By Form (Value)
          • 8.1.6.1.1.1. Powder
          • 8.1.6.1.1.2. Liquid
          • 8.1.6.1.1.3. Encapsulated
          • 8.1.6.1.1.4. Others
      • 8.1.6.2. India
        • 8.1.6.2.1. By Form (Value)
          • 8.1.6.2.1.1. Powder
          • 8.1.6.2.1.2. Liquid
          • 8.1.6.2.1.3. Encapsulated
          • 8.1.6.2.1.4. Others
      • 8.1.6.3. Japan
        • 8.1.6.3.1. By Form (Value)
          • 8.1.6.3.1.1. Powder
          • 8.1.6.3.1.2. Liquid
          • 8.1.6.3.1.3. Encapsulated
          • 8.1.6.3.1.4. Others
      • 8.1.6.4. Southeast Asia
        • 8.1.6.4.1. By Form (Value)
          • 8.1.6.4.1.1. Powder
          • 8.1.6.4.1.2. Liquid
          • 8.1.6.4.1.3. Encapsulated
          • 8.1.6.4.1.4. Others
      • 8.1.6.5. Australia
        • 8.1.6.5.1. By Form (Value)
          • 8.1.6.5.1.1. Powder
          • 8.1.6.5.1.2. Liquid
          • 8.1.6.5.1.3. Encapsulated
          • 8.1.6.5.1.4. Others
      • 8.1.6.6. Rest of Asia Pacific
        • 8.1.6.6.1. By Form (Value)
          • 8.1.6.6.1.1. Powder
          • 8.1.6.6.1.2. Liquid
          • 8.1.6.6.1.3. Encapsulated
          • 8.1.6.6.1.4. Others

9. South America Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 9.1. By Product Type (Value)
    • 9.1.1. Food and Beverages
      • 9.1.1.1. Dairy-based products
        • 9.1.1.1.1. Non-dairy based beverages
        • 9.1.1.1.2. Cereals & snacks
        • 9.1.1.1.3. Baked food
        • 9.1.1.1.4. Frozen & confectionery
        • 9.1.1.1.5. Ready-to-eat packaged meals
      • 9.1.1.2. Supplements
        • 9.1.1.2.1. Nutritional supplements
        • 9.1.1.2.2. Specialty supplements
        • 9.1.1.2.3. Infant formula
      • 9.1.1.3. Animal Feed
      • 9.1.1.4. Cosmetics
    • 9.1.2. By Source (Value)
      • 9.1.2.1. Bacteria
        • 9.1.2.1.1. Lactobacillus
        • 9.1.2.1.2. Bifidobacterium
        • 9.1.2.1.3. Others
      • 9.1.2.2. Yeast
      • 9.1.2.3. Others
    • 9.1.3. By Form (Value)
      • 9.1.3.1. Powder
        • 9.1.3.1.1. Liquid
        • 9.1.3.1.2. Encapsulated
        • 9.1.3.1.3. Others
    • 9.1.4. By End Use (Value)
      • 9.1.4.1. Human
        • 9.1.4.1.1. Animal
    • 9.1.5. By Distribution Channel (Value)
      • 9.1.5.1. Supermarkets & Hypermarkets
        • 9.1.5.1.1. Pharmacies & Drug Stores
        • 9.1.5.1.2. Health & Specialty Stores
        • 9.1.5.1.3. Online Retail / E-commerce
        • 9.1.5.1.4. Others
    • 9.1.6. By Country
      • 9.1.6.1. Brazil
        • 9.1.6.1.1. By Form (Value)
          • 9.1.6.1.1.1. Powder
          • 9.1.6.1.1.2. Liquid
          • 9.1.6.1.1.3. Encapsulated
          • 9.1.6.1.1.4. Others
      • 9.1.6.2. Argentina
        • 9.1.6.2.1. By Form (Value)
          • 9.1.6.2.1.1. Powder
          • 9.1.6.2.1.2. Liquid
          • 9.1.6.2.1.3. Encapsulated
          • 9.1.6.2.1.4. Others
      • 9.1.6.3. Rest of South America
        • 9.1.6.3.1. By Form (Value)
          • 9.1.6.3.1.1. Powder
          • 9.1.6.3.1.2. Liquid
          • 9.1.6.3.1.3. Encapsulated
          • 9.1.6.3.1.4. Others

10. Middle East & Africa Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 10.1. Key Findings / Summary
    • 10.1.1. By Product Type (Value)
      • 10.1.1.1. Food and Beverages
        • 10.1.1.1.1. Dairy-based products
        • 10.1.1.1.2. Non-dairy based beverages
        • 10.1.1.1.3. Cereals & snacks
        • 10.1.1.1.4. Baked food
        • 10.1.1.1.5. Frozen & confectionery
        • 10.1.1.1.6. Ready-to-eat packaged meals
      • 10.1.1.2. Supplements
        • 10.1.1.2.1. Nutritional supplements
        • 10.1.1.2.2. Specialty supplements
        • 10.1.1.2.3. Infant formula
      • 10.1.1.3. Animal Feed
      • 10.1.1.4. Cosmetics
    • 10.1.2. By Source (Value)
      • 10.1.2.1. Bacteria
        • 10.1.2.1.1. Lactobacillus
        • 10.1.2.1.2. Bifidobacterium
        • 10.1.2.1.3. Others
      • 10.1.2.2. Yeast
      • 10.1.2.3. Others
    • 10.1.3. By Form (Value)
      • 10.1.3.1. Powder
        • 10.1.3.1.1. Liquid
        • 10.1.3.1.2. Encapsulated
        • 10.1.3.1.3. Others
    • 10.1.4. By End Use (Value)
      • 10.1.4.1. Human
        • 10.1.4.1.1. Animal
    • 10.1.5. By Distribution Channel (Value)
      • 10.1.5.1. Supermarkets & Hypermarkets
        • 10.1.5.1.1. Pharmacies & Drug Stores
        • 10.1.5.1.2. Health & Specialty Stores
        • 10.1.5.1.3. Online Retail / E-commerce
        • 10.1.5.1.4. Others
    • 10.1.6. By Country
      • 10.1.6.1. UAE
        • 10.1.6.1.1. By Form (Value)
          • 10.1.6.1.1.1. Powder
          • 10.1.6.1.1.2. Liquid
          • 10.1.6.1.1.3. Encapsulated
          • 10.1.6.1.1.4. Others
      • 10.1.6.2. South Africa
        • 10.1.6.2.1. By Form (Value)
          • 10.1.6.2.1.1. Powder
          • 10.1.6.2.1.2. Liquid
          • 10.1.6.2.1.3. Encapsulated
          • 10.1.6.2.1.4. Others
      • 10.1.6.3. Rest of MEA
        • 10.1.6.3.1. By Form (Value)
          • 10.1.6.3.1.1. Powder
          • 10.1.6.3.1.2. Liquid
          • 10.1.6.3.1.3. Encapsulated
          • 10.1.6.3.1.4. Others

11. Competitive Matrix

  • 11.1. Business Strategies Adopted by Leading Players
  • 11.2. Global Probiotics Market Revenue Share/Ranking Analysis, By Key Manufacturer, 2025

12. Company Profiles

  • 12.1. Yakult Honsha Co., Ltd.
    • 12.1.1. Overview
    • 12.1.2. Description
    • 12.1.3. Type Portfolio
    • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.1.5. Recent Developments

13. Similar in information has been provided for all the below companies

  • 13.1. Danone S.A.
  • 13.2. Nestle S.A.
  • 13.3. Chr. Hansen Holding A/S
  • 13.4. DuPont Nutritona dn Biosciences
  • 13.5. BioGaia AB
  • 13.6. Probi AB
  • 13.7. ADM
  • 13.8. Kerry Group Plc
  • 13.9. Meiji Holdings Co., Ltd.

14. Strategic Recommendations

15. Appendix

List of Tables

  • Table 1: Global Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 2: Global Probiotics Market Value (USD Billion), by Source, 2021-2034
  • Table 3: Global Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 4: Global Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 5: Global Probiotics Market Value (USD Billion), by Distribution Channel, 2021-2034
  • Table 6: Global Probiotics Market Value (USD Billion), by Region, 2021-2034
  • Table 7: North America Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 8: North America Probiotics Market Value (USD Billion), by Source, 2021-2034
  • Table 9: North America Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 10: North America Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 11: North America Probiotics Market Value (USD Billion), by Distribution Channel, 2021-2034
  • Table 12: North America Probiotics Market Value (USD Billion), by Country, 2021-2034
  • Table 13: U.S. Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 14: Canada Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 15: Mexico Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 16: Europe Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 17: Europe Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 18: Europe Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 19: Europe Probiotics Market Value (USD Billion), by End User, 2021-2034
  • Table 20: Europe Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 21: Europe Probiotics Market Value (USD Billion), by Country, 2021-2034
  • Table 22: Germany Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 23: U.K. Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 24: France Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 25: Italy Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 26: Spain Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 27: Rest of Europe Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 28: Asia Pacific Probiotics Market Value (USD Billion), by Source, 2021-2034
  • Table 29: Asia Pacific Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 30: Asia Pacific Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 31: Asia Pacific Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 32: Asia Pacific Probiotics Market Value (USD Billion), by Country, 2021-2034
  • Table 33: China Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 34: India Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 35: Japan Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 36: Australia Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 37: Rest of Asia Pacific Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 38: South America Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 39: South America Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 40: South America Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 41: South America Probiotics Market Value (USD Billion), by Source, 2021-2034
  • Table 42: South America Probiotics Market Value (USD Billion), by Distribution Channel, 2021-2034
  • Table 43: South America Probiotics Market Value (USD Billion), by Country, 2021-2034
  • Table 44: Brazil Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 45: Argentina Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 46: Rest of South America Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 47: Middle East and Africa Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 48: Middle East and Africa Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 49: Middle East and Africa Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 50: Middle East and Africa Probiotics Market Value (USD Billion), by Source, 2021-2034
  • Table 51: Middle East and Africa Probiotics Market Value (USD Billion), by Distribution Channel, 2021-2034
  • Table 52: Middle East and Africa Probiotics Market Value (USD Billion), by Country, 2021-2034
  • Table 53: UAE Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 54: South Africa Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 55: Rest of MEA Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 56: Global Probiotics Market, Ranking Analysis (2025)

List of Figures

  • Figure 1: Global Probiotics Market (USD Billion), 2025 and 2034
  • Figure 2: Global Probiotics Market, By Product Type, 2025 and 2034, (USD Billion)
  • Figure 3: Global Probiotics Market, By Form, 2025 and 2034, (USD Billion)
  • Figure 4: Global Probiotics Market, By End Use, 2025 and 2034, (USD Billion)
  • Figure 5: Global Probiotics Market, By Source, 2025 and 2034, (USD Billion)
  • Figure 6: Global Probiotics Market, By Distribution Channel, 2025 and 2034, (USD Billion)
  • Figure 7: Global Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 8: Global Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 9: Global Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 10: Global Probiotics Market Value Share (%), by Form, 2025
  • Figure 11: Global Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 12: Global Probiotics Market Value Share (%), by End Use, 2025
  • Figure 13: Global Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 14: Global Probiotics Market Value Share (%), by Source, 2025
  • Figure 15: Global Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 16: Global Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 17: Global Probiotics Market Value (USD Billion), By Region, 2025 & 2034
  • Figure 18: Global Probiotics Market Share (%), By Region, 2025
  • Figure 19: North America Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 20: North America Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 21: North America Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 22: North America Probiotics Market Value Share (%), by Form, 2025
  • Figure 23: North America Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 24: North America Probiotics Market Value Share (%), by End Use, 2025
  • Figure 25: North America Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 26: North America Probiotics Market Value Share (%), by Source, 2025
  • Figure 27: North America Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 28: North America Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 29: North America Probiotics Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 30: North America Probiotics Market Value Share (%), by Country, 2025
  • Figure 31: U.S. Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 32: U.S. Probiotics Market Value Share (%), by Form, 2025
  • Figure 33: Canada Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 34: Canada Probiotics Market Value Share (%), by Form, 2025
  • Figure 35: Mexico Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 36: Mexico Probiotics Market Value Share (%), by Form, 2025
  • Figure 37: Europe Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 38: Europe Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 39: Europe Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 40: Europe Probiotics Market Value Share (%), by Form, 2025
  • Figure 41: Europe Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 42: Europe Probiotics Market Value Share (%), by End Use, 2025
  • Figure 43: Europe Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 44: Europe Probiotics Market Value Share (%), by Source, 2025
  • Figure 45: Europe Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 46: Europe Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 47: Europe Probiotics Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 48: Europe Probiotics Market Share (%), by Country, 2025
  • Figure 49: Germany Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 50: Germany Probiotics Market Value Share (%), by Form, 2025
  • Figure 51: U.K. Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 52: U.K. Probiotics Market Value Share (%), by Form, 2025
  • Figure 53: France Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 54: France Probiotics Market Value Share (%), by Form, 2025
  • Figure 55: Italy Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 56: Italy Probiotics Market Value Share (%), by Form, 2025
  • Figure 57: Spain Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 58: Spain Probiotics Market Value Share (%), by Form, 2025
  • Figure 59: Rest of Europe Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 60: Rest of Europe Probiotics Market Value Share (%), by Form, 2025
  • Figure 61: Asia Pacific Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 62: Asia Pacific Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 63: Asia Pacific Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 64: Asia Pacific Probiotics Market Value Share (%), by Form, 2025
  • Figure 65: Asia Pacific Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 66: Asia Pacific Probiotics Market Value Share (%), by End Use, 2025
  • Figure 67: Asia Pacific Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 68: Asia Pacific Probiotics Market Value Share (%), by Source, 2025
  • Figure 69: Asia Pacific Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 70: Asia Pacific Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 71: Asia Pacific Probiotics Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 72: Asia Pacific Probiotics Market Value Share (%), by Country, 2025
  • Figure 73: China Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 74: China Probiotics Market Value Share (%), by Form, 2025
  • Figure 75: India Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 76: India Probiotics Market Value Share (%), by Form, 2025
  • Figure 77: Japan Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 78: Japan Probiotics Market Value Share (%), by Form, 2025
  • Figure 79: Australia Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 80: Australia Probiotics Market Value Share (%), by Form, 2025
  • Figure 81: Southeast Asia Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 82: Southeast Asia Probiotics Market Value Share (%), by Form, 2025
  • Figure 83: Rest of APAC Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 84: Rest of APAC Probiotics Market Value Share (%), by Form, 2025
  • Figure 85: South America Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 86: South America Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 87: South America Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 88: South America Probiotics Market Value Share (%), by Form, 2025
  • Figure 89: South America Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 90: South America Probiotics Market Value Share (%), by End Use, 2025
  • Figure 91: South America Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 92: South America Probiotics Market Value Share (%), by Source, 2025
  • Figure 93: South America Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 94: South America Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 95: South America Probiotics Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 96: South America Probiotics Market Value Share (%), by Country, 2025
  • Figure 97: Brazil Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 98: Brazil Probiotics Market Value Share (%), by Form, 2025
  • Figure 99: Argentina Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 100: Argentina Probiotics Market Value Share (%), by Form, 2025
  • Figure 101: Rest of South America Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 102: Rest of South America Probiotics Market Value Share (%), by Form, 2025
  • Figure 103: Middle East & Africa Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 104: Middle East & Africa Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 105: Middle East & Africa Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 106: Middle East & Africa Probiotics Market Value Share (%), by Form, 2025
  • Figure 107: Middle East & Africa Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 108: Middle East & Africa Probiotics Market Value Share (%), by End Use, 2025
  • Figure 109: Middle East & Africa Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 110: Middle East & Africa Probiotics Market Value Share (%), by Source, 2025
  • Figure 111: Middle East & Africa Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 112: Middle East & Africa Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 113: Middle East & Africa Probiotics Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 114: Middle East & Africa Probiotics Market Value Share (%), by Country, 2025
  • Figure 115: UAE Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 116: UAE Probiotics Market Value Share (%), by Form, 2025
  • Figure 117: South Africa Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 118: South Africa Probiotics Market Value Share (%), by Form, 2025
  • Figure 119: Rest of South America Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 120: Rest of South America Probiotics Market Value Share (%), by Form, 2025
  • Figure 121: Global Probiotics Market, Most Adopted Strategies, 2021-2026